Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

2.
3.

Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.

Kuklin N, Daheshia M, Karem K, Manickan E, Rouse BT.

J Virol. 1997 Apr;71(4):3138-45.

5.

An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.

Khalil SM, Tonkin DR, Snead AT, Parks GD, Johnston RE, White LJ.

J Virol. 2014 Aug;88(16):9182-96. doi: 10.1128/JVI.00327-14. Epub 2014 Jun 4.

6.
8.
11.

Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract.

Gallichan WS, Woolstencroft RN, Guarasci T, McCluskie MJ, Davis HL, Rosenthal KL.

J Immunol. 2001 Mar 1;166(5):3451-7.

13.

Influence of CCR7 ligand DNA preexposure on the magnitude and duration of immunity.

Lee Y, Eo SK, Rouse RJ, Rouse BT.

Virology. 2003 Jul 20;312(1):169-80.

14.

Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.

Wizel B, Persson J, Thörn K, Nagy E, Harandi AM.

Vaccine. 2012 Jun 19;30(29):4361-8. doi: 10.1016/j.vaccine.2012.02.019.

PMID:
22682292
15.
16.

Vaginal memory T cells induced by intranasal vaccination are critical for protective T cell recruitment and prevention of genital HSV-2 disease.

Sato A, Suwanto A, Okabe M, Sato S, Nochi T, Imai T, Koyanagi N, Kunisawa J, Kawaguchi Y, Kiyono H.

J Virol. 2014 Dec;88(23):13699-708. doi: 10.1128/JVI.02279-14. Epub 2014 Sep 17.

17.

Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.

Cui FD, Asada H, Kishida T, Itokawa Y, Nakaya T, Ueda Y, Yamagishi H, Gojo S, Kita M, Imanishi J, Mazda O.

Gene Ther. 2003 Dec;10(25):2059-66.

PMID:
14595378
18.

Immunization with HSV-2 gB-CCL19 Fusion Constructs Protects Mice against Lethal Vaginal Challenge.

Yan Y, Hu K, Deng X, Guan X, Luo S, Tong L, Du T, Fu M, Zhang M, Liu Y, Hu Q.

J Immunol. 2015 Jul 1;195(1):329-38. doi: 10.4049/jimmunol.1500198. Epub 2015 May 20.

19.
20.

Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity.

Lauterbach H, Ried C, Epstein AL, Marconi P, Brocker T.

J Gen Virol. 2005 Sep;86(Pt 9):2401-10.

PMID:
16099897

Supplemental Content

Support Center